AU2017903766A0 - Composition and method for treating autism - Google Patents

Composition and method for treating autism

Info

Publication number
AU2017903766A0
AU2017903766A0 AU2017903766A AU2017903766A AU2017903766A0 AU 2017903766 A0 AU2017903766 A0 AU 2017903766A0 AU 2017903766 A AU2017903766 A AU 2017903766A AU 2017903766 A AU2017903766 A AU 2017903766A AU 2017903766 A0 AU2017903766 A0 AU 2017903766A0
Authority
AU
Australia
Prior art keywords
composition
treating autism
autism
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017903766A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zelda Therapeutics Operations Pty Ltd
Original Assignee
Zelda Therapeutics Operations Pty Ltd
Filing date
Publication date
Application filed by Zelda Therapeutics Operations Pty Ltd filed Critical Zelda Therapeutics Operations Pty Ltd
Publication of AU2017903766A0 publication Critical patent/AU2017903766A0/en
Priority to CA3075122A priority Critical patent/CA3075122A1/en
Priority to JP2020515668A priority patent/JP2021500312A/en
Priority to AU2018101357A priority patent/AU2018101357B4/en
Priority to AU2018333282A priority patent/AU2018333282A1/en
Priority to CN201880068202.6A priority patent/CN111263638A/en
Priority to PCT/AU2018/051010 priority patent/WO2019051560A1/en
Priority to US16/646,055 priority patent/US20200276155A1/en
Priority to EP18856402.5A priority patent/EP3681525A4/en
Priority to SG11202002169TA priority patent/SG11202002169TA/en
Priority to CL2020000632A priority patent/CL2020000632A1/en
Priority to IL273278A priority patent/IL273278A/en
Priority to US18/323,860 priority patent/US20230364052A1/en
Abandoned legal-status Critical Current

Links

AU2017903766A 2017-09-15 2017-09-15 Composition and method for treating autism Abandoned AU2017903766A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SG11202002169TA SG11202002169TA (en) 2017-09-15 2018-09-14 Composition and method for treating autism
CN201880068202.6A CN111263638A (en) 2017-09-15 2018-09-14 Compositions and methods for treating autism
JP2020515668A JP2021500312A (en) 2017-09-15 2018-09-14 Compositions and methods for the treatment of autism
AU2018101357A AU2018101357B4 (en) 2017-09-15 2018-09-14 Composition and method for treating autism
AU2018333282A AU2018333282A1 (en) 2017-09-15 2018-09-14 Composition and method for treating autism
CA3075122A CA3075122A1 (en) 2017-09-15 2018-09-14 Composition and method for treating autism
PCT/AU2018/051010 WO2019051560A1 (en) 2017-09-15 2018-09-14 Composition and method for treating autism
US16/646,055 US20200276155A1 (en) 2017-09-15 2018-09-14 Composition and method for treating autism
EP18856402.5A EP3681525A4 (en) 2017-09-15 2018-09-14 Composition and method for treating autism
CL2020000632A CL2020000632A1 (en) 2017-09-15 2020-03-11 Composition and method for the treatment of autism.
IL273278A IL273278A (en) 2017-09-15 2020-03-12 Composition and method for treating autism
US18/323,860 US20230364052A1 (en) 2017-09-15 2023-05-25 Composition and method for treating autism

Publications (1)

Publication Number Publication Date
AU2017903766A0 true AU2017903766A0 (en) 2017-10-05

Family

ID=

Similar Documents

Publication Publication Date Title
EP3681525A4 (en) Composition and method for treating autism
EP3626803A4 (en) Composition and method for producing composition
EP3247359A4 (en) Composition and method for treating seizure disorders
EP3328562A4 (en) Clean-place method and system and composition for the same
EP3297618A4 (en) Methods and kits for treating depression
EP3193862A4 (en) Cannabinoid composition and method for treating pain
EP3704227A4 (en) Composition and method
EP3612215A4 (en) Compositions and methods for treating lung inflammation
EP3359663A4 (en) Composition and method for treating complement-mediated disease
IL254963A0 (en) Compositions and methods for treating autism
EP3471746A4 (en) Method and composition for treating seizure disorders
EP3436427A4 (en) Method and composition for treating neuronal hyper-excitability
EP3590361A4 (en) Luteolin-containing composition and method for manufacturing same
ZA201907283B (en) Compositions, devices and methods for treating autism
EP3352729A4 (en) Method and compositions for treating skin
EP3411367A4 (en) Compositions and methods for treating infections
EP3391897A4 (en) Hemostatic composition and hemostatic method using hemostatic composition
EP3345987A4 (en) Free-polyunsaturated-fatty-acid-containing composition and method for manufacturing same
EP3727452A4 (en) Compositions and methods for treating neoplasia
EP3685845A4 (en) Composition and method for producing same
EP3534913A4 (en) Composition and method for treating otitis
EP3559115A4 (en) Composition and method for producing composition
EP3823593A4 (en) Compositions and methods for treating autism
AU2018301500A1 (en) Methods and compositions for treating inflammation
EP3590360A4 (en) Lutein-containing composition and method for manufacturing same